The decision is made with 89% of the adult population with the complete vaccination schedule.
Aspiring For Better Healthcare Support Becoming an Additional Ground To Explore Higher Studies Abroad
Healthcare protocols seem to have garnered Indian students' attention well
On Sunday, Union health minister Mansukh Mandaviya, informed that the Drugs Controller General of India (DCGI) has granted emergency-use permission to the vaccine
Today, Pfizer is profiting from Covid-19. But the vaccines have shown that mRNA technology can be used effectively. And that opens the door for future PFE stock growth
The decision drew immediate pushback, with experts noting that young, healthy people are at low risk of severe COVID-19 and at elevated risk of heart inflammation following vaccination.
The new Johnson & Johnson company will focus on the medical devices and pharmaceuticals business, which sells its COVID-19 vaccine and other drugs.
Aaron Rodgers divides his sponsors amid the controversy surrounding his Covid-19 vaccine status and comments.
Regeneron said its monoclonal antibody treatment reduced the risk of contracting the disease by 81.6 percent among uninfected persons.
After approval from the FDA's vaccine-advisory board, the option could be on the table as soon as next week.
The Fed's so-called Beige Book noted that the U.S. economy has been "dampened by a low supply of workers," partially due to vaccine mandates.
Indiana family said their two young children got two full adult doses of the Pfizer COVID-19 vaccine instead of influenza shots.
The phase 3 trial preliminary results showed the drug cut the risk of developing severe COVID-19 or dying by 50 percent compared to a placebo in people who did not require hospitalization and had been showing symptoms for a week or less.
Leisure and hospitality job growth between March and August 2021 averaged nearly 12 percent in the highest quartile states for vaccination, and less than 4 percent in the states in the lowest quartile, according to the report.
Pfizer and BioNTech SE Submit Data on Covid Vaccine for Kids 5-11 to FDA; Emergency Use Authorization Could Come By Halloween
The pharmaceutical companies are confident they're one step closer to making vaccination an option for millions of younger children.